Cellectis vs Lesaka Technologies
CLLS and LSAK side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CLLS and LSAK compare
Cellectis grew revenue faster over the last twelve months (75.8% versus 9.4% for Lesaka Technologies).
Lesaka Technologies keeps more of each dollar of sales as profit, with a net margin of 0.38% compared with −92.7% at Cellectis.
Lesaka Technologies scores higher on the StockData Score (6 against 3 for Cellectis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CLLS | LSAK |
|---|---|---|
| Size and price | ||
| Market cap | – | $269M |
| Share price | $0.921 | $3.14 |
| Change, 1 year | −79.1% | −18.0% |
| Change, 5 years | −89.4% | −35.1% |
| Beta (5Y) | 2.12 | 0.56 |
| Employees | 229 | 3,900 |
| StockData Score | ||
| Total score | 3 | 6 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 1 | 1 |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 105× |
| P/S | – | 0.4× |
| P/B | – | 1.3× |
| EV/EBITDA | – | 6.6× |
| P/FCF | – | 8.5× |
| FCF yield | – | 11.8% |
| Fair value | – | $1.96 |
| Margin of safety | – | −60.4% |
| Growth | ||
| Revenue growth (TTM) | 75.8% (better) | 9.4% |
| Revenue growth, 5Y average | 7.4% | 40.7% (better) |
| Profitability | ||
| Gross margin | 100% (better) | 32.0% |
| Operating margin | −45.3% | 1.8% (better) |
| Net margin | −92.7% | 0.38% (better) |
| FCF margin | −57.2% | 4.4% (better) |
| Return on equity | −97.8% | 1.5% (better) |
| Return on invested capital | −122% | 2.5% (better) |
| Financial health | ||
| Debt / equity | – | 1.03 |
| Net debt / EBITDA | – | 2.15 |
| Interest coverage | −0.6× | 0.7× (better) |
| Current ratio | – | 1.59 |
| Altman Z-score | – | 2.09 |
| Piotroski F-score | 3 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 0.13% |
| Shareholder yield | – | 0.13% |
| Ownership | ||
| Held by institutions | 9.4% | 25.3% |
| Held by insiders | 53.4% | 11.8% |
| Insider net buying, 12 months | – | $5.7M |
| Short interest, % of float | – | 0.56% |
Go deeper
- CLLS stock overview
- CLLS income statement
- CLLS valuation and score
- LSAK stock overview
- LSAK income statement
- LSAK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.